Globe Newswire » trang 190 » Trang Công Nghệ | Trangcongnghe.vn

Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评

Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评

Globenewswire -

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

Globenewswire -

WeRide’s WRD 3.0 Makes History as the Only Four‑Time Champion at China Urban Intelligent Driving Competition

WeRide’s WRD 3.0 Makes History as the Only Four‑Time Champion at China Urban Intelligent Driving Competition

Globenewswire -

YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026

YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026

Globenewswire -

Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter

Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter

Globenewswire -

Bodor Laser Ranked No. 1 in Global Sales Volume for Seven Consecutive Years, Demonstrating Brand Strength Through Sustained Leadership

Globenewswire -

JETOUR to Unveil “Travel+” Strategy at Auto China 2026

JETOUR to Unveil “Travel+” Strategy at Auto China 2026

Globenewswire -

XEM THÊM TIN MỚI